Differentiation of the mammary gland and susceptibility to carcinogenesis (original) (raw)

References

  1. Muir R: The evolution of carcinoma of the mamma. J Pathol Bacteriol 52: 155–172, 1941.
    Google Scholar
  2. Humphrey LJ, Swerdlow M: Relationship of benign breast disease to carcinoma of the breast. Surgery 52: 841–846, 1962.
    PubMed Google Scholar
  3. Ryan JA, Coady CJ: Ductal proliferation in breast cancer. Can J Surg 5: 12–19, 1962.
    PubMed Google Scholar
  4. Sandison AT: An autopsy study of the adult human breast. Natl Cancer Inst Monogr 4: 1–145, 1962.
    PubMed Google Scholar
  5. Tanaka Y, Oota K: A stereomicroscopic study of the mastopathic human breast. I. Three dimensional structures of abnormal duct evolution and their histologic entity. Virch Arch (Path Anat) 349: 195–214, 1970.
    Google Scholar
  6. Dawson EK: A histological study of the normal mamma in relation to tumour growth. I. Early development to maturity. Edinb Med J 41: 653–682, 1934.
    Google Scholar
  7. Dawson EK: A histological study of the normal mamma in relation to tumour growth. II. The mature gland in pregnancy and lactation. Edinb Med J 42: 569–598, 1935.
    Google Scholar
  8. Fraser J: A study of the malignant breast by whole section and key block section methods. Surg Gynecol Obstet 45: 266–286, 1927.
    Google Scholar
  9. Fraser J: The breast in health and disease. Edinb Med J 36: 217–241, 1929.
    Google Scholar
  10. Cheatle GL: Desquamative and dysgenetic epithelial hyperplasia in breast: Their situation and characteristics: Their likeness to lesions induced by tar. Br J Surg 13: 509–532, 1926.
    Google Scholar
  11. Dawson EK: Carcinoma in the mammary lobule and its origin. Edinb Med J 40: 57–82, 1933.
    Google Scholar
  12. Dawson EK: Mammary cancer and the menopause. Edinb Med J 50: 721–736, 1943.
    Google Scholar
  13. Dawson EK: The genesis and spread of mammary cancer. Ann R Coll Surg Engl 2: 241–247, 1948.
    Google Scholar
  14. Dawson EK: Premalignant conditions in breast cancer.In L Severi (ed): The morphological precursors of cancer. Perugia University Press, Perguia, 1962, pp 383–388.
    Google Scholar
  15. Cole WH, Rossiter LJ: Chronic cystic mastitis: With particular reference to classification. Ann Surg 119: 573–590, 1944.
    Google Scholar
  16. Geschickter CF: Diseases of the breast: Diagnosis, pathology, treatment. Lipincott, Philadelphia, 1945, pp 413.
    Google Scholar
  17. Foote FW, Stewart FW: Comparative studies of cancerous verus noncancerous breasts. Ann Surg 121: 6–53, 1945.
    Google Scholar
  18. Foote FW, Stewart FW: Comparative studies of cancerous versus noncancerous breasts. Ann Surg 121: 197–222, 1945.
    Google Scholar
  19. Black MM, Chabon AB: In situ carcinoma of the breast.In SC Sommers (ed): Pathology Annual. Appleton-Century-Crofts, New York, 1969, pp 185–210.
    Google Scholar
  20. Gallager HS, Martin JE: Early phases in the development of breast cancer. Cancer 24: 1170–1178, 1969.
    PubMed Google Scholar
  21. Kern WHJ, Brooks RN: A typical epithelial hyperplasia associated with breast cancer and fibrocystic disease. Cancer 24: 668–675, 1969.
    PubMed Google Scholar
  22. Welling SR, Jensen HM, Marcum RG: An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55: 231–273, 1975.
    PubMed Google Scholar
  23. Vorherr H: Development of the female breast.In The Breast. Academic Press, New York, 1974, pp 1–18.
    Google Scholar
  24. Ashikari R, Hajda SI, Robbins GF: Intraductal carcinoma of the breast. Cancer 28: 1182–1187, 1971.
    PubMed Google Scholar
  25. MacMahon B, Cole P, Liu M, Lowe CR, Mirra AP, Ravinihar B, Salber EJ, Valaoras VG, Yuasa S: Age at first birth and breast cancer risk. Bull WHO 34: 209–221, 1970.
    Google Scholar
  26. Valaoras VG, MacMahon B, Trichopoulos D, Polychronopoulou A: Lactation and reproductive histories of breast cancer patients in greater Athens, 1965–1967. Int J Cancer 4: 350–363, 1969.
    PubMed Google Scholar
  27. Lim TM, Chen KP, MacMahon B: Epidemiologic characteristics of cancer of the breast in Taiwan. Cancer 27: 1497–1504, 1971.
    PubMed Google Scholar
  28. Parnihar B, MacMahon B, Lindtner J: Epidemiologic features of breast cancer in Slovenia, 1965–1967. Europ J Cancer 7: 295–306, 1971.
    Google Scholar
  29. Yuasa S, MacMahon B: Lactation and reproductive histories of breast cancer patients in Tokyo, Japan Bull WHO 42: 195–204, 1970.
    Google Scholar
  30. Shapiro S, Strax P, Venet L: The search for risk factors in breast cancer. Am J Public Health 58: 820–835, 1968.
    Google Scholar
  31. Salber EJ, Trichopoulos D, MacMahon B: Lactation and reproductive histories of breast cancer patients in Boston. J Natl Cancer Inst 43: 1013–1024, 1969.
    PubMed Google Scholar
  32. Segi M, Fukushima I, Fujisaku S: An epidemiological study on cancer in Japan. Gann 48 (Suppl): 1–63, 1957.
    Google Scholar
  33. Staszewski J: Age at menarche and breast cancer. J Natl Cancer Inst 47: 935–940, 1971.
    PubMed Google Scholar
  34. Ingleby H, Gerchon-Cohen J: Comparative anatomy, pathology, and roentgenology of the breast. University of Pennsylvania Press, Philadelphia, 1960, pp 291–309.
    Google Scholar
  35. Kiaer W: Relation of fibroadenomatosis (chronic mastitis) to cancer of the breast. Munksgaard, Copenhagen, 1954, pp 159.
    Google Scholar
  36. Parks AG: The micro-anatomy of the breasts. Ann R Coll Surg Engl 24: 235–251, 1959.
    Google Scholar
  37. Bonser GM, Dossett JA, Jull JW: Cyclic disease and epithelial proliferation as precancerous conditions in the human breast.In Human and Experimental Breast Cancer. Charles C Thomas, Springfield Ill, 1971, pp 316–363.
    Google Scholar
  38. McLaughlin CW, Schenken JR, Tamisiea JX: A study of precancerous epithelial hyperplasia and noninvasive papillary carcinoma of the breast. Ann Surg 153: 735–744, 1961.
    PubMed Google Scholar
  39. Mirra AP, Cole P, MacMahon B: Breast cancer in an area of high parity: Sao Paulo, Brazil. Cancer Res 31: 77–83, 1971.
    PubMed Google Scholar
  40. Lilienfeld AM: The relationship of cancer of the female breast to artificial menopause and marital status. Cancer 9: 927–934, 1956.
    PubMed Google Scholar
  41. Logan WPD: Marriage and childbearing in relation to cancer of the breast and uterus. Lancet 2: 1199–1202, 1953.
    Google Scholar
  42. Damon A: Host factors in cancer of the breast and uterine cervix and corpus. J Natl Cancer Inst 24: 483–516, 1960.
    PubMed Google Scholar
  43. Stewart HL, Dunham LJ, Casper J, Dorn HF, Thomas LB, Edgcomb JH, Symeonidis A: Epidemiology of uterine cervix and corpus, breast and ovary in Israel and New York City. J Natl Cancer Inst 37: 1–95, 1966.
    Google Scholar
  44. Sherman BM, Korenman SG: Inadequate corpus luteum function: A pathophysiological interpretation of human breast cancer epidemiology. Cancer 33: 1306–1312, 1974.
    PubMed Google Scholar
  45. Bulbrook RD, Hayward JL, Spicer CC, Thomas BS: Urinary steroid excretion of normal women and women with advanced breast cancer. Lancet ii: 1235–1240, 1962.
    Google Scholar
  46. Bulbrook RD, Hayward JL, Thomas BS: The relation between urinary 17-hydroxycorticosteroids and 11-deoxy-17-oxosteroids and the fate of patients with mastectomy. Lancet i: 945–947, 1964.
    Google Scholar
  47. Kumaoka S, Sakauchi N, Abe O, Kusama M, Takatani I: Urinary 17-ketosteroid excretion of women with advanced breast cancer. J Clin Endocrinol Metab 28: 667–672, 1968.
    PubMed Google Scholar
  48. Bulbrook RD, Hayward JL, Spicer CC: Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet ii: 395–398, 1971.
    Google Scholar
  49. Wade AP, Davis JC, Tweedie MC: The discriminant function in early carcinoma of the breast. Lancet 1: 863–857, 1969.
    PubMed Google Scholar
  50. Wade AP, Davis JC, Tweedie MC: Discriminants and breast cancer. Lancet 2: 54, 1969.
    Google Scholar
  51. Kaplan SD, Acheson RM: A single etiological hypothesis for breast cancer? J Chronic Dis 19: 1221–1230, 1966.
    PubMed Google Scholar
  52. Hirayama T, Wynder EL: A study of the epidemiology of cancer of the breast. Cancer 15: 28–38, 1962.
    Google Scholar
  53. Feinleib M: Breast cancer and artificial menopause: A cohort study. J Natl Cancer Inst 41: 315–329, 1968.
    PubMed Google Scholar
  54. Grattarola R: The premenstrual endometrial pattern of women with breast cancer. Cancer 17: 1119–1122, 1964.
    PubMed Google Scholar
  55. MacMahon B, Cole P: Endocrinology and epidemiology of breast cancer. Cancer 24: 1146–1150, 1969.
    PubMed Google Scholar
  56. Levin ML, Sheehe PR, Graham S, Glidewell O: Lactation and menstrual function as related to cancer of the breast. Am J Public Health 54: 580–587, 1964.
    Google Scholar
  57. Lemon HM, Wotiz HH, Parsons L, Mozden PJ: Reduced estriol excretion in patients with breast cancer prior to endocrine therapy. J Am Med Assoc 196: 1128–1136, 1966.
    Google Scholar
  58. Lemon HM: Endocrine influences on human mammary cancer formation. Cancer 23: 781–790, 1969.
    PubMed Google Scholar
  59. Gronroos M, Aho AJ: Estrogen metabolism in postmenopausal women with primary and recurrent breast cancer. Europ J Cancer 4: 523–527, 1968.
    Google Scholar
  60. Marmorston J, Crowley LG, Myers SM, Stern E, Hopkins CE: Urinary excretion of estrone, estradiol and estriol by patients with breast cancer and benign breast disease. Am J Obstet Gynecol 92: 460–467, 1965.
    PubMed Google Scholar
  61. Wynder EL, Bross JJ, Hirayama T: A study of the epidemiology of cancer of the breast. Cancer 13: 559–601, 1960.
    PubMed Google Scholar
  62. MacMahon B, Feinlieb M: Breast cancer in relation to nursing and menopausal history. J Natl Cancer Inst 24: 733–753, 1960.
    PubMed Google Scholar
  63. Sunkara PS, Rao PN, Nishioka K: Role of putrescine in DNA synthesis and mitosis of mammalian cells (Abstract). Proc Am Assoc Cancer Res 18: 84, 1977.
    Google Scholar
  64. McGregor DH, Land CE, Choi K, Tokuoka S, Liv PI: Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950–69. J Natl Cancer Inst 59: 799–811, 1977.
    PubMed Google Scholar
  65. Mackenzie I: Breast cancer following multiple fluoroscopies. Br J Cancer 19: 1–8, 1965.
    PubMed Google Scholar
  66. Myrden JA, Hiltze JE: Breast cancer following multiple fluoroscopies during artificial pneumothorax treatment of pulmonary tuberculosis. Can Med Assoc J 100: 1032–1034, 1969.
    PubMed Google Scholar
  67. Boice JD, Monson RR: Breast cancer in women after repeated fluoroscopic examination of the chest. J Natl Cancer Inst 59: 823–832, 1977.
    PubMed Google Scholar
  68. Higginson J: The role of geographical pathology in environmental carcinogenesis.In Twenty-fourth Annual Symposium on Fundamental Cancer Research: Environment and Cancer. Williams and Wilkins, Baltimore, 1972, pp 69–79.
    Google Scholar
  69. Haenzel W, Kurikara V: Studies of Japanese migrants I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40: 43–68, 1968.
    PubMed Google Scholar
  70. Commoner B, Vithayathil AJ, Dolara P, Sabhadra N, Madyastha P, Cuca GC: Formation of mutagens in beef and beef extract during cooking. Science 201: 913–916, 1978.
    PubMed Google Scholar
  71. Grasso P, O'Hare C: Carcinogens in food.In CE Searles (ed): Chemical Carcinogens. ACS Monograph, Washington, D.C., 1976, pp 701–728.
    Google Scholar
  72. Surgeon General's Report, ‘Smoking and Health’. Government Printing Office, Public Health Service Publication No. 79-50066, Washington, D.C., 1979.
  73. In ‘Particulate Polycyclic Organic Matter’. Washington, D.C., National Academy of Sciences, 1972.
  74. Petrakis NL, Mason L, Lee R, Sugimoto B, Pawson S, Catchpool F: Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration. J Natl Cancer Inst 54: 829–833, 1975.
    PubMed Google Scholar
  75. Petrakis NL: Genetic cerumen type, breast secretory activity, and breast cancer epidemiology.In JS Mulvihill, RW Miller, JF Fraumeni Jr (eds): Genetics of Human Cancer. Raven Press, New York, 1977, pp 297–300.
    Google Scholar
  76. Russo J, Saby J, Isenberg W, Russo IH: Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 59: 435–445, 1977.
    Google Scholar
  77. Dablow A: Die Milchdruse.In W Bargmann (ed): Handbuch der mikroskopischen Anatomie des Menschen, Vol 3, Part 3. Haut und Sinnes Organs. Springer-Verlag, Berlin, 1957, pp 277–485.
    Google Scholar
  78. Boston collaborative drug surveillance program: Relation between breast cancer and S blood antigen system. Lancet 1: 301–305, 1971.
    Google Scholar
  79. Armstrong B: Recent trends in breast cancer incidence and mortality in relation to changes in possible risk factors. Int J Cancer 17: 204–211, 1976.
    PubMed Google Scholar
  80. MacMahon B: Risk factors for endometrial cancer. Gynecol Oncol 2: 122–129, 1974.
    PubMed Google Scholar
  81. Li FP, Fraumeni JF: Soft tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71: 747–752, 1969.
    PubMed Google Scholar
  82. Anderson DE: Some characteristics of familial breast cancer. Cancer 28: 1500–1504, 1971.
    PubMed Google Scholar
  83. Morosini P, Lee EG, Jones MN: Breast cancer and the S blood group system. Lancet 1: 411–412, 1972.
    PubMed Google Scholar
  84. Patel R, Habal MB, Wilson RE: Histocompatibility (HL-A) antigens and cancer of the breast. Am J Surg 124: 31–34, 1972.
    PubMed Google Scholar
  85. Petrakis NL: Cerumen genetics and human breast cancer. Science 173: 347–349, 1971.
    PubMed Google Scholar
  86. Lilienfeld AM: The epidemiology of breast cancer. Cancer Res 23: 1503–1513, 1963.
    PubMed Google Scholar
  87. Post RH: Breast cancer, lactation, and genetics. Eugen Quart 13: 1–29, 1966.
    Google Scholar
  88. Vakil DV, Morgan RW: Etiology of breast cancer. I. Genetic aspects. Can Med Assoc J 109: 29–32, 1973.
    PubMed Google Scholar
  89. Anderson DE: A genetic study of human breast cancer. J Natl Cancer Inst 48: 1029–1034, 1972.
    PubMed Google Scholar
  90. Mazzaleni GF: Rapporti di frequenza fra carcinoma mammario e gravidanza. Riv Anat Pathol Oncol 17: 243–260, 1960.
    Google Scholar
  91. Bonser GM, Dossett JA, Jull JW: Human and experimental breast cancer. Charles C Thomas, Publisher, Springfield, Ill, 1961, pp 397–410.
    Google Scholar
  92. Cutler M: Tumors of the breast. JB Lippincott Co, Philadelphia, 1962, pp 148–158.
    Google Scholar
  93. Juret P, Couette JE, Mandard AM, Carre A, Delozier T, Brune D, Vernhes JC: Age and menarche as a prognostic factor in human breast cancer. Eur J Cancer 12: 701–704, 1976.
    PubMed Google Scholar
  94. Wotiz HH, Shane JA, Vigersky R, Brecher PI: The regulatory role of oestriol in the proliferative action of oestradiol.In AP Forest and PB Kunkler (eds): Prognostic Factors in Breast Cancer. Longman, London, 1968, pp 368–377.
    Google Scholar
  95. Cole P, MacMahon B: Oestrogen fractions during early reproductive life in the aetiology of breast cancer. Lancet 1: 604–606, 1969.
    PubMed Google Scholar
  96. MacMahon B: Etiology of human breast cancer. J Natl Cancer Inst 50: 21–42, 1973.
    PubMed Google Scholar
  97. Juret P, Couette JE, Brune D, Vernhes JC: L'age à la premiere naissance: une variable à la signification simple, double ou triple eu cancerologie mammaire. Bull Cancer (Paris) 62: 165–174, 1975.
    Google Scholar
  98. Russo J, Russo IH, Ireland M, Saby J: Increased resistance of multiparous rat mammary gland to neoplastic transformation by 7,12-dimethylbenz(a)anthracene (Abstract). Proc Am Assoc Cancer Res 18: 149, 1977.
    Google Scholar
  99. Dao TL: Carcinogenesis of mammary gland in rat. Prog Exp Tumor Res 5: 157–216, 1964.
    Google Scholar
  100. Moon RC: Relationship between previous reproductive history and chemically induced mammary cancer in rats. Int J Cancer 4: 312–317, 1969.
    PubMed Google Scholar
  101. Huggins C, Briziarelli G, Sutton H: Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med 109: 25–54, 1959.
    PubMed Google Scholar
  102. Murad T, von Haam E: Studies of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene administration. Cancer Res 32: 1404–1415, 1972.
    PubMed Google Scholar
  103. Huggins C, Grand LC, Brillantes FP: Critical significance of breast structure in the induction of mammary cancer in the rat. Proc Natl Acad Sci USA 45: 1294–1300, 1959.
    Google Scholar
  104. McCormick GM, Moon RC: Effect of pregnancy and lactation on growth of mammary tumors induced by 7,12-dimethylbenz(a)anthracene (DMBA). Br J Cancer 19: 160–166, 1965.
    PubMed Google Scholar
  105. Dao TL, Bock FG, Greiner MJ: Mammary carcinogenesis by 3-methylcholanthrene. II. Inhibitory effect of pregnancy and lactation on tumor induction. J Natl Cancer Inst 25: 991–1003, 1960.
    PubMed Google Scholar
  106. Higginson J, Muir CS: Epidemiology.In JF Holland and E Frei III (eds): Cancer Medicine. Lea and Febiger, Philadelphia, 1974, pp 241–306.
    Google Scholar
  107. Miller JA, Miller EC: The metabolic activation of carcinogenic aromatic amines and amides. Prog Exp Tumor Res 11: 273–301, 1969.
    PubMed Google Scholar
  108. Huberman E, Sachs L: Cell susceptibility to transformation and cytotoxicity by the carcinogenic hydrocarbon benzo(a) pyrene. Proc Natl Acad Sci USA 56: 1123–1129, 1966.
    PubMed Google Scholar
  109. Brookes P, Lawley PD: Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: Relation between carcinogenic power of hydrocarbons and their binding to DNA. Nature 202: 781–784, 1964.
    PubMed Google Scholar
  110. Kuroki T, Heidelberger C: The binding of polycyclic aromatic hydrocarbons to the DNA, RNA and proteins of transformable cells in culture. Cancer Res 31: 2168–2176, 1971.
    PubMed Google Scholar
  111. Nagasawa H, Yanai R: Frequency of mammary cell division in relation to age: Its significance in the induction of mammary tumors by carcinogen in rats. J Natl Cancer Inst 52: 609–610, 1974.
    PubMed Google Scholar
  112. Nagasawa H: Causes of age-dependency of mammary tumour induction by carcinogens in rats. Biomedicine 34: 9–11, 1981.
    PubMed Google Scholar
  113. McCarter JA, Quastler H: Effect of dimethylbenzanthracene on the cellular proliferation cycle. Nature 194: 873–874, 1962.
    Google Scholar
  114. Bertram JS, Heidelberger C: Cell cycle dependency on oncogenic transformation induced by N-methyl-N'-nitro-N-nitrosoguanidine in culture. Cancer Res 34: 526–537, 1974.
    PubMed Google Scholar
  115. Marquardt H: Cell cycle dependence of chemically induced malignant transformation in vitro. Cancer Res 34: 1612–1615, 1974.
    PubMed Google Scholar
  116. Little JB, Hahn GM: Life-cycle dependence of repair of potentially-lethal radiation damage. Int J Radiat Biol Relat Stud Phys Chem Med 23: 401–407, 1972.
    Google Scholar
  117. Heidelberger C: Chemical carcinogenesis. Ann Rev Biochem 44: 72–121, 1975.
    Google Scholar
  118. Irving CC: Interaction of chemical carcinogens with DNA,In H Busch (ed): Methods in Cancer Research. Academic Press, New York, 1973, pp 189–244.
    Google Scholar
  119. Miller EC, Miller JA: Mechanisms of chemical carcinogenesis: Nature of proximate carcinogens and interactions with macromolecules. Pharm Rev 18: 805–838, 1966.
    PubMed Google Scholar
  120. Dipple A, Lawley PD, Brookes P: Theory of tumor initiation by chemical carcinogens, dependence of activity on structure of ultimate carcinogens. Europ J Cancer 4: 493–502, 1968.
    Google Scholar
  121. Shag H, Friedmann B, Gruenstein M, Weinhouse S: Mammary excretion of 20-methylcholanthrene. Cancer Res 10: 797–800, 1950.
    PubMed Google Scholar
  122. Grubbs CJ, Moon RC: Effect of age and parity upon the uptake of 9,10-dimethyl-1,2-benz(a)anthracene-9-14C by mammary parenchymal cells of the rat. Br J Cancer 31: 189–196, 1975.
    PubMed Google Scholar
  123. Janss DH, Moon RC: Effect of endocrine organ ablation on uptake and clearance of 9,10-dimethyl-1,2-benzanthracene-9-14C by mammary parenchymal cells of the rat. Cancer Res 31: 2026–2031, 1971.
    PubMed Google Scholar
  124. Miller JA: Carcinogenesis by chemicals: An overview — G.H.A. Clowes Memorial Lecture. Cancer Res 30: 559–576, 1970.
    PubMed Google Scholar
  125. Grover PL, Hewer A, Sims P: Epoxides as microsomal metabolites of polycyclic hydrocarbons. FEBS Lett 18: 76–80, 1971.
    PubMed Google Scholar
  126. Jerina DM, Daly JW, Witkop B, Zaltzmann-Nurenburg P, Udenfriend S: Role of the arene oxide-oxepine system in the metabolism of aromatic substrates. I. In vitro conversion of benzeneoxide to a premercapturic acid and a dihydrodiol. Arch Biochem Biophys 128: 176–183, 1968.
    Google Scholar
  127. Jerina DM, Daly JW, Witkop B, Zaltzman-Nurenburg P, Udenfriend S: 1,2-Naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene. Biochemistry 9: 147–155, 1970.
    PubMed Google Scholar
  128. Lawley PD, Tratcher CJ: Methylation of deoxyribonucleic acid in cultured mammalian cells by N-methyl-N'-nitro-N-nitrosoguanidine. The influence of cellular thiol concentrations on the extent of methylation and the 6-oxygen atom of guanine as a site of methylation. Biochem J 116: 693–707, 1970.
    PubMed Google Scholar
  129. Grover PL, Forrester JA, Sims P: Reactivity of the K-region epoxides of some polycyclic hydrocarbons towards the nucleic acids and proteins of BHK 21 cells. Biochem Pharmacol 20: 1297–1302, 1971.
    PubMed Google Scholar
  130. Grover PL, Sims P: Interactions of the K-region epoxides of phenanthrene and dibenz(a,h)anthracene with nucleic acids and histones. Biochem Pharmacol 19: 2251–2259, 1970.
    PubMed Google Scholar
  131. Huebner R, Todaro G: Oncogenesis of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci USA 64: 1087–1094, 1969.
    PubMed Google Scholar
  132. Yamamoto T, Rabinowitz Z, Sachs L: Identification of the chromosomes that control malignancy. Nature (New Biol) 243: 247, 1973.
    Google Scholar
  133. Temin HM: On the origin of the genes for neoplasia: G.H.A. Clowes Memorial Lecture. Cancer Res 34: 2835–2841, 1974.
    PubMed Google Scholar
  134. Tamulski TS, Morreal CE, Dao TL: Comparative metabolism of 7,12-dimethylbenz(a)anthracene in liver and mammary tissue. Cancer Res 33: 3117–3122, 1973.
    PubMed Google Scholar
  135. Pound AW: The influence of preliminary irritation by acetic acid or croton oil on skin tumour production in mice after a single application of dimethylbenzanthracene, benzopyrene or dibenzanthracene. Br J Cancer 22: 533–544, 1968.
    PubMed Google Scholar
  136. Chernozemski IN, Warick GP: Liver regeneration and induction of hepatomas in B6AF mice by urethan. Cancer Res 30: 2685–2690, 1970.
    PubMed Google Scholar
  137. Bowden GT, Shapas BG, Boutwell RK: The binding of 7,12-dimethylbenz(a)-anthracene to replicating and nonreplicating DNA in mouse skin. Chem Biol Interact 8: 379–394, 1974.
    PubMed Google Scholar
  138. Janss DH, Hadaway EI: Effect of strain and age on the binding of 7,12-dimethylbenz(a)anthracene (DMBA) to rat mammary epithelial cell macromolecules (Abstract). Proc Am Assoc Cancer Res 18: 208, 1977.
    Google Scholar
  139. Coggin JH, Anderson NG: Cancer, differentiation and embryonic antigens: Some central problems. Adv Cancer Res 19: 105–165, 1974.
    PubMed Google Scholar
  140. Brown RJ: Possible association of embryonal antigen(s) with several primary 3-methylcholanthrene-induced murine sarcomas. Int J Cancer 6: 245–249, 1970.
    PubMed Google Scholar
  141. Cannon GB, Bonnard GD, Djeu J, West W, Herberman RB: Relationship of human natural lymphocyte-mediated cytotoxicity to cytotoxicity of breast-cancer-derived target cells. Int J Cancer 19: 487–497, 1977.
    PubMed Google Scholar
  142. Coggin JH, Ambrose KR, Anderson NG: Phase specific surface autoantigens on membranes of fetus and tumors. Adv Exp Biol Med 29: 483–490, 1973.
    Google Scholar
  143. Girardi AJ, Reppucci P, Dierlam P, Rutala W, Coggin J: Prevention of simian virus 40 tumors by hamster fetal tissue: Influence of parity status of donor females on immunogenicity of fetal tissue and on immune cell cytotoxicity. Proc Natl Acad Sci USA 70: 183–186, 1973.
    PubMed Google Scholar
  144. Anderson NJ, Coggin JH: Embryonic antigens in virally transformed cells.In SB Day and RA Good (eds): Membranes and Viruses in Immunopathology. Academic Press, New York, 1972, pp 217–219.
    Google Scholar
  145. Winslow S: Masters Thesis, Univ Tennessee, Univ Tennessee Press, Knoxville, 1972.
  146. Kellen JA, Cocuzzi E: Resistance to a transplantable rat mammary tumor (DMBA SBT) after pretreatment with fetal cells (Abstract). Proc Am Assoc Cancer Res 18: 39, 1977.
    Google Scholar
  147. Butle GAH, Eperson J, Menzies DN: Induced tumor resistance in rats. Lancet 2: 12–14, 1964.
    Google Scholar
  148. Prehn RT: The significance of tumor-distinctive histocompatibility antigens.In JJ Trentin (ed); Cross-reacting Antigens and Neoantigens, Williams and Wilkins, Baltimore, 1967, pp 105–119.
    Google Scholar
  149. Ting RC: Failure to induce transplantation resistance against polyoma tumour cells with syngeneic embryonic tissues. Nature 217: 858–859, 1968.
    PubMed Google Scholar
  150. Blair PB: Search for cross-reacting antigenicity between mammary tumor virus-induced mammary tumors and embryonic antigens: Effect of immunization on development of spontaneous mammary tumors. Cancer Res 30: 1199–1202, 1970.
    PubMed Google Scholar
  151. Trosko JE, Chu EH: The role of DNA repair and somatic mutation in carcinogenesis. Adv Cancer Res 21: 391–425, 1975.
    PubMed Google Scholar
  152. Nagao M, Sugimura T: Molecular biology of the carcinogen, 4-nitro-quinoline 1-oxide.In G Klein and S Weinhouse (eds): Advances in Cancer Research 23. Academic Press, New York, 1976, pp 132.
    Google Scholar
  153. Cowie AT, Folley SJ: The role of the adrenal cortex in mammary development and its relation to the mammogenic action of the anterior pituitary. Endocrinol 40: 274–285, 1947.
    Google Scholar
  154. Benson GJ, Cowie AT, Cox CP, Goldzveic SA: Effects of oestrone and progesterone on mammary development in the guinea pig. J Endocrinol 15: 126–144, 1957.
    PubMed Google Scholar
  155. DeOme KB, Faulkin LJ, Bern MA, Blair P: Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 19: 515–520, 1959.
    PubMed Google Scholar
  156. Raynaud A: Morphogenesis of the mammary gland.In SK Kon and AT Cowie (eds): Milk: The Mammary Gland and Its Secretions. Academic Press, New York, 1961, pp 3–44.
    Google Scholar
  157. Cowie AT, Folley SJ: The mammary gland and lactation.In WC Young (ed): Sex and Internal Secretions. Williams and Wilkens, Baltimore, 1961, pp 590–642.
    Google Scholar
  158. Russo IH, Saby J, Isenberg W: Early signs of malignant transformation in rat mammary carcinoma (Abstract). Proc Am Assoc Cancer Res 17: 463, 1976.
    Google Scholar
  159. Russo J, Russo IH: DNA labeling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. J Natl Cancer Inst 61: 1451–1459, 1978.
    PubMed Google Scholar
  160. Furmanski P, Longley C, Fouchey D, Rich R, Rich M: Normal human mammary cells in culture: Evidence for oncornavirus-like particles. J Natl Cancer Inst 52: 975–978, 1974.
    PubMed Google Scholar
  161. Russo J, Furmanski P, Rich MA: An ultrastructural study of normal human mammary epithelial cells in culture. Am J Anat 142: 221–232, 1975.
    PubMed Google Scholar
  162. Russo J, Furmanski P, Bradley R, Wells P, Rich M: Differentiation of normal human mammary epithelial cells in culture. Am J Anat 145: 57–63, 1976.
    PubMed Google Scholar
  163. Cowie AT: The relative growth of the mammary gland in normal, gonadectomized and adrenalectomized rats. J Endocrinol 6: 145–157, 1949.
    PubMed Google Scholar
  164. Silver M: A quantitative analysis of the role of oestrogen in mammary development in the rat. J Endocrinol 10: 17–34, 1953.
    PubMed Google Scholar
  165. Cole HA: The mammary gland of the mouse during the oestrus cycle, pregnancy and lactation. Proc R Soc Biol Sci 114: 136–150, 1933.
    Google Scholar
  166. Turner CW, Schultze AB: A study of the causes of the normal development of the mammary glands of the albino rat. Mo Agric Sta, Columbia Res Bull 157, 1931.
  167. Vorherr H: Suppression of post-partum lactation. Postgrad Med 52: 145–152, 1972.
    PubMed Google Scholar
  168. Tyson JE, Hwang P, Guyda H, Friesen HG: Studies of prolactin secretion in human pregnancy. Amer J Obstet Gynecol 113: 14–20, 1972.
    Google Scholar
  169. Tyson JE, Blizzard RM: Prolactin and thyrotropin secretion in human pregnancy (Abstract). Clin Res 20: 443, 1972.
    Google Scholar
  170. Berle P, Apostolakis M: Prolaktin-Konzentrationen im menschlichen Plasma während Schwangerschaft und Wochenbett. Acta Endocrinol 67: 63–72, 1971.
    PubMed Google Scholar
  171. Forbes TR: Absorption of crystalline testosterone, testosterone proprionate, methyl testosterone, progesterone, desoxycorticosterone and stilbestrol implanted in the rat. Endocrinol 29: 70–76, 1941.
    Google Scholar
  172. Chalterton RT: Progesterone and mammary gland development.In KW McKerns (ed): The Sex Steroids — Molecular Mechanisms. Appleton Century-Crofts, New York, 1971, pp 345–382.
    Google Scholar
  173. Bassler R: The morphology of hormone induced structural changes in the female breast. Curr Top Pathol 53: 1–89, 1970.
    PubMed Google Scholar
  174. Toker C: Observations on the ultrastructure of a mammary ductule. J Ultrastruct Res 21: 9–25, 1967.
    PubMed Google Scholar
  175. Sterling JW, Chandler JA: The fine structure of the normal, resting terminal ductal-lobular unit of the female breast. Virchows Arch Abt A Pathol Anat Histol 372: 205–226, 1976.
    Google Scholar
  176. Russo IH, Ireland M, Isenberg W, Russo J: Ultrastructural description of three different epithelial cell types in rat mammary gland (Abstract). Proc Electron Microscopy Soc Am 34: 146–147, 1976.
    Google Scholar
  177. Russo J, Isenberg W, Ireland M, Russo IH: Ultrastructural changes in the mammary epithelial cell population during neoplastic development induced by a chemical carcinogen (Abstract). Proc Electron Microscopy Soc Am 34: 250–251, 1976.
    Google Scholar
  178. Sinha DK, Dao TL: A direct mechanism of mammary carcinogenesis induced by 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 53: 841–846, 1974.
    PubMed Google Scholar
  179. Huggins C, Grand LC, Brillantes FP: Mammary cancer induced by a single feeding of polynuclear hydrocarbons, and its suppression. Nature 189: 204–207, 1967.
    Google Scholar
  180. Huggins C, Yang NC: Induction and extinction of mammary cancer. Science 137: 257–262, 1962.
    PubMed Google Scholar
  181. Payne S: The pathological effects of the intraperitoneal injection of 3,4-benzpyrene into rats and mice. Br J Cancer 12: 65–74, 1958.
    PubMed Google Scholar
  182. Pataki J, Huggins C: Molecular site of substituents of benz(a) anthracene related to carcinogenicity. Cancer Res 29: 506–509, 1969.
    PubMed Google Scholar
  183. Russo IH, Russo J: Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 61: 1439–1449, 1978.
    PubMed Google Scholar
  184. Haslam SZ, Bern HA: Histopathogenesis of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Proc Natl Acad Sci USA 74: 4020–4024, 1977.
    PubMed Google Scholar
  185. Medina D: Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice. J Natl Cancer Inst 57: 1185–1189, 1976.
    PubMed Google Scholar
  186. Clemens JA, Welsch CW, Meites J: Effects of hypothalmic lesions on incidence and growth of mammary tumors in carcinogen-treated rats. Proc Soc Exp Biol Med 127: 969–972, 1968.
    PubMed Google Scholar
  187. Welsch CW, Clemens JA, Meites J: Effects of multiple pituitary homografts or progesterone on 7,12-dimethylbenz(a)anthracene-induced tumors in rats. J Natl Cancer Inst 41: 465–471, 1968.
    PubMed Google Scholar
  188. Marchant J: The inhibitory effect of continued lactation on the incidence of chemically-induced breast tumours in mice of the IF strain. Br J Cancer 12: 55–61, 1958.
    PubMed Google Scholar
  189. Russo J: DNA synthesis and terminal end bud density in mammary gland as determinants of susceptibility to carcinogens (Abstract). Proc Am Assoc Cancer Res 19: 228, 1978.
    Google Scholar
  190. Ciocca DR, Russo J: Prolactin levels in susceptible and non-susceptible rats to DMBA carcinogenesis (Abstract). Proc 3rd Ann Cancer Res Conf Ohio Valley — Lake Erie Assoc Cancer Centers, Detroit, Michigan, 1980, pp 27.
  191. Yuasa S, MacMahon B: Lactation and reproductive histories of breast cancer patients in Tokyo, Japan. Bull WHO 42: 192–204, 1970.
    Google Scholar
  192. Marchant J: Influence of pregnancy and lactation on the incidence of mammary carcinoma induced with methylcholanthrene in female mice of the ‘IF’ strain. J Pathol Bacteriol 70: 415–418, 1955.
    PubMed Google Scholar
  193. Marchant J: Local inhibition by lactation of chemically induced breast tumors in mice of the IF strain. Nature 183: 629, 1959.
    Google Scholar
  194. Russo J, Wilgus G, Russo IH: Susceptibility of the mammary gland to carcinogenesis. l. Differentiation of the mammary gland as determinant of tumor incidence and type of lesion. Am J Pathol 96: 721–736, 1979.
    PubMed Google Scholar
  195. Dao TL, Sunderland H: Mammary carcinogenesis by 3-methylcholanthrene. l. Hormonal aspects in tumor induction and growth. J Natl Cancer Inst 23: 567–581, 1959.
    PubMed Google Scholar
  196. Kledzick GS, Bradley CJ, Meites J: Reduction of carcinogen-induced mammary cancer incidence in rats by early treatment with hormones or drugs. Cancer Res 34: 2953–2956, 1974.
    PubMed Google Scholar
  197. Spellacy WN: Immunoassay of human placental lactogens: Physiological studies on normal and abnormal pregnancy.In GEW Wolster-Holm and J Knight (eds): Lactogenic Hormones. Churchill Livingston, London, 1972 pp 223–235.
    Google Scholar
  198. Nagasawa H, Yanai R: Effect of human placental lactogen on growth of carcinogen-induced mammary tumors in rats. Int J Cancer 11: 131–137, 1973.
    PubMed Google Scholar
  199. Russo IH: Topographical differences in cell cycle and growth fraction as determinants of the site of origin of mammary carcinoma (Abstract). Proc Am Assoc Cancer Res 20: 230, 1979.
    Google Scholar
  200. Wilgus G, Russo J: Cell cycle and growth fraction of virgin and parous rat mammary gland as determinants of different susceptibility to carcinogenesis (Abstract). Proc Am Assoc Cancer Res 20: 238, 1979.
    Google Scholar
  201. McCormick GM, Moon RC: Effect of increasing doses of estrogen and progesterone on mammary carcinogenesis in the rat. Europ J Cancer 9: 483–486, 1973.
    Google Scholar
  202. Welsch CW, Meites J: Effects of a norethynodrel-mestranol combination (enovid) on development and growth of carcinogen-induced mammary tumors in female rats. Cancer 23: 601–607, 1969.
    PubMed Google Scholar
  203. Hwang P, Guyda H, Friesen H: A radioimmunoassay for human prolactin. Proc Natl Acad Sci USA 68: 1902–1906, 1971.
    PubMed Google Scholar
  204. Roy EJ, Mackay R: The concentration of oestrogens in blood during pregnancy. J Obstet Gynaecol Br Empire 69: 13–17, 1962.
    Google Scholar
  205. Short RV: Progesterone.In CH Grey and AL Bacharach (eds): Hormones in Blood. Academic Press, New York, 1961, pp 379–437.
    Google Scholar
  206. Yoshimi T, Strott CA, Marshall JR, Lipsett MB: Corpus luteum function in early pregnancy. J Clin Endocrinol Metab 29: 225–230, 1969.
    PubMed Google Scholar
  207. Russo J, Russo IH: Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res 40: 2677–2687, 1980.
    PubMed Google Scholar
  208. Russo J, Tay LK, Wilgus G: Effect of 7,12-dimethylbenz(a) anthracene (DMBA) on rat mammary epithelial cells in culture (Abstract). Fed Proc 38: 1249, 1979.
    Google Scholar
  209. Tay LK, Russo J: 7,12-Dimethylbenz(a)anthracene-induced DNA binding and repair synthesis in susceptible and nonsusceptible mammary epithelial cells in culture. J Natl Cancer Inst 67: 155–161, 1981.
    PubMed Google Scholar
  210. Ceriani RL, Thompson K, Peterson JA: Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule. Proc Natl Acad Sci USA 74: 582–586, 1977.
    PubMed Google Scholar
  211. Ceriani RL, Peterson JA: Characterization of difantigens of the mouse mammary epithelial cell (MME antigens) carried on the mouse milk fat globule. Cell Diff 7: 355–360, 1978.
    Google Scholar
  212. Thompson K, Ceriani RL, Wong D, Abraham S: Immunologic methods for the identification of cell types. I. Specific antibodies that distinguish between mammary gland epithelial cells and fibroblasts. J Natl Cancer Inst 57: 167–172, 1976.
    PubMed Google Scholar
  213. Ceriani RL, Peterson JA, Abraham S: Immunologic methods for the identification of cell types. II. Expression of normal mouse mammary epithelial cell antigens in mammary neoplasia. J Natl Cancer Inst 61: 747–751, 1978.
    PubMed Google Scholar
  214. Fitzgerald DK, Brodbeck U, Kiyosawa I, Mawal B, Colvin B, Ebner KE:_α_-Lactalbumin and the lactose synthetase reaction. J Biol Chem 245: 2103–2108, 1970.
    PubMed Google Scholar
  215. Kuhn NJ: Lactogenesis in the rat. Metabolism of uridine diphosphate galactose by mammary gland. Biochem J 106: 743–748, 1968.
    PubMed Google Scholar
  216. McKenzie L, Fitzgerald DK, Ebner KE: Lactose synthetase activities in rat and mouse mammary glands. Biochem Biophys Acta 230: 526–530, 1971.
    PubMed Google Scholar
  217. Palmiter RD: Hormonal induction and regulation of lactose synthetase in mouse mammary gland. Biochem J 113: 409–417, 1969.
    PubMed Google Scholar
  218. Turkington RW, Brew K, Vanaman TC, Hill RL: The hormonal control of lactose synthetase in the developing mouse mammary gland. J Biol Chem 243: 3382–3387, 1968.
    PubMed Google Scholar
  219. Russo J, Wells P: Light microscopic localization of cytochemical reactions in epoxy-embedded material for electron microscopy. J Histochem Cytochem 23: 921–931, 1975.
    PubMed Google Scholar
  220. Russo J, Wells P: Ultrastructural localizations of adenosine triphosphatase activity in resting mammary gland. J Histochem Cytochem 25: 135–148, 1977.
    PubMed Google Scholar
  221. Russo J, Wilgus G: Growth kinetics of rat mammary gland epithelial cells in culture (Abstract). In Vitro 15: 35, 1979.
    Google Scholar
  222. Russo J, Wilgus G, Tait L, Russo IH: Influence of age and parity on the susceptibility of rat mammary gland epithelial cells in primary cultures to 7,12-dimethylbenz(a)anthracene. In Vitro 17: 877–884, 1981.
    PubMed Google Scholar
  223. Hayflick L: The Limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37: 614–635, 1965.
    PubMed Google Scholar
  224. Martin GM, Sprague CA, Epstein CJ: Replicative life-span of cultivated human cells. Lab Invest 23: 86–92, 1970.
    PubMed Google Scholar
  225. Goldstein S, Littlefield JW, Soeldner JS: Diabetes mellitus and aging. Diminished plating efficiency of cultured human fibroblasts. Proc Natl Acad Sci USA 64: 155–160, 1970.
    Google Scholar
  226. Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585–621, 1961.
    Google Scholar
  227. Schneider EL, Mitsui Y: The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci USA 73: 3584–3588, 1976.
    PubMed Google Scholar
  228. Voyles BA, McGrath CM: Differential response of maligant BALB/c mammary epithelial cells to the multiplicationstimulating activity of insulin. J Natl Cancer Inst 62: 597–603, 1979.
    PubMed Google Scholar
  229. Shunkin MB, Gruenstein M, Thatcher D, Baserga R: Tritiated thymidine labeling of cells in rats following exposure to 7,12-dimethylbenz(a)anthracene. Cancer Res 27: 1494–1495, 1967.
    PubMed Google Scholar
  230. Tong C, Fazio M, Williams GM: Cell cycle-specific mutagenesis at the hypoxanthine phosphoribosyltransferase locus in adult rat liver epithelial cells. Proc Natl Acad Sci USA 77: 7377–7379, 1980.
    PubMed Google Scholar
  231. Prodi G, Rocchi P, Grilli S: Binding of 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene to nucleic acids and proteins of organs in rats. Cancer Res 30: 1020–1023, 1970.
    PubMed Google Scholar
  232. Tominaga T, Dao TL, Libby PR: Effects of 7,12-dimethylbenz(a)anthracene on RNA polymerase in isolated mammary gland cell nuclei. Proc Soc Exp Biol Med 136: 694–697, 1971.
    PubMed Google Scholar
  233. Pound AW: Carcinogenesis and cell proliferation. NZ Med J 67: 88–99, 1968.
    Google Scholar
  234. Marquardt H, Bendick A, Phillips FS: Binding of [G-3H] 7,12-dimethylbenz(a)anthracene and hepatic neoplasia in regenerating rat liver. Chem-Biol Interact 3: 1–11, 1971.
    PubMed Google Scholar
  235. Tominaga T, Libby PR, Dao TL: An early effect of 7,12-dimethylbenz(a)anthracene on rat mammary gland DNA synthesis. Cancer Res 30: 118–122, 1970.
    PubMed Google Scholar
  236. Schneider EL, Chaillet JR, Tice RR: In vivo BUdR labeling of mammalian chromosomes. Exp Cell Res 100: 396–399, 1976.
    PubMed Google Scholar
  237. Schneider EL, Sternberg H, Tice RR: In vivo analysis of cellular replication. Proc Natl Acad Sci USA 74: 2041–2044, 1977.
    PubMed Google Scholar
  238. Perry P, Wolff S: New giemsa method for the differential staining of sister chromatids. Nature 251: 156–158, 1974.
    PubMed Google Scholar
  239. Krain D, Schneider EL, Singer L, Martin GR: The effects of high and low fluoride diets on the frequency of sister chromatid exchanges. Mutat Res 57: 51–55, 1978.
    PubMed Google Scholar
  240. Nakanishi Y, Schneider EL: In vivo sister chromatid exchange: A sensitive measure of DNA damage. Mutat Res 60: 329–337, 1979.
    PubMed Google Scholar
  241. Schneider EL: Cell replication and aging: in vitro and in vivo studies. Fed Proc 38: 1857–1867, 1979.
    PubMed Google Scholar
  242. Tice RR, Schneider EL, Krain D, Thorne P: Cytokinetic analysis of the impaired proliferative response of peripheral lymphocytes from aged humans to phytohemagglutinin. J Exp Med 149: 1029–1041, 1979.
    PubMed Google Scholar
  243. Abe S, Kakata S, Sandberg AA: Growth rate and sister chromatid exchange (SCE) incidence of bone marrow cells in acute myeloblastic leukemia (AML). Cancer Genet Cytogenet 1: 115–130, 1979.
    Google Scholar
  244. Abe S, Sandberg AA: Sister chromatid exchange and growth kinetics of bone marrow cells in aneuploid acute nonlymphocytic leukemias. Cancer Res 40: 1292–1299, 1980.
    PubMed Google Scholar
  245. Voyles BA, McGrath CM: Markers to distinguish normal and neoplastic mammary epithelial cells in vitro: Comparison of saturation density morphology and concanavalin A reactivity. Int J Cancer 18: 498–509, 1976.
    PubMed Google Scholar
  246. Asch BB, Medina D, Brinkley BR: Microtubules and actincontaining filaments of normal, preneoplastic, and neoplastic mouse mammary epithelial cells. Cancer Res 39: 893–907, 1979.
    PubMed Google Scholar
  247. Das NK, Hosick HL, Nandi S: Influence of seeding density on multicellular organization and nuclear events in cultures of normal and neoplastic mouse mammary epithelium. J Natl Cancer Inst 52: 849–861, 1974.
    PubMed Google Scholar
  248. Pickett PB, Pitelka DR, Hamamoto ST, Mispeldt DS: Occluding junctions and cell behavior in primary cultures of normal and neoplastic mammary gland cells. J Cell Biol 66: 316–332, 1975.
    PubMed Google Scholar
  249. Asch BB, Medina D: Concanavalin A-induced agglutinability of normal, preneoplastic, and neoplastic mouse mammary cells. J Natl Cancer Inst 61: 1423–1430, 1978.
    PubMed Google Scholar
  250. Furmanski P, Phillips PG, Subin M: Cell surface interactions with concanavalin A: Determination by hemadsorption. Proc Soc Exp Biol Med 140: 216–219, 1972.
    PubMed Google Scholar
  251. Iype PT, Pontzes CH: Identification of transformed liver cell colonies using concanavalin A attached to agarose beads. Cancer Res 40: 4663–4668, 1980.
    PubMed Google Scholar
  252. Voyles BA, Kirkland WL, Furmanski P, McGrath CM: Concanavalin A hemadsorption by normal and malignant human mammary epithelial cells. Cancer Res 38: 1578–1583, 1978.
    PubMed Google Scholar
  253. Nicholson GL: Difference in the topology of normal and tumor cell membranes shown by different surface distributions of ferritin-conjugated concanavalin A. Nature (New Biol) 233: 244–246, 1971.
    Google Scholar
  254. Inbar M, Ben-Basset H, Sach L: Membrane changes associated with malignancy. Nature 236: 3–16, 1972.
    Google Scholar
  255. Ozanne B, Sambrook J: Binding of radioactively labeled concanavalin A and wheat germ agglutinin to normal and transformed cells. Nature (New Biol) 232: 156–160, 1971.
    Google Scholar
  256. Cline MJ, Livingston DC: Binding of3H-concanavalin A by normal and transformed cells. Nature (New Biol) 232: 155–156, 1971.
    Google Scholar
  257. Wetzel B, Kendig EM, Jones GM, Sanford KK: A systematic scanning electron microscope analysis of mitotic cell populations in monolayer culture. Scan Elec Micr 11: 949–958, 1978.
    Google Scholar
  258. Shohan J, Sachs L: Different cyclic changes in the surface membrane of normal and malignant transformed cells. Exp Cell Res 85: 8–14, 1974.
    PubMed Google Scholar
  259. Allen TD, Iype PT: The surface morphology of normal and malignant rat liver epithelial cells in culture. In Vitro 12: 837–843, 1976.
    PubMed Google Scholar
  260. Russo J, Russo IH: Cell surface characteristics of a human breast carcinoma cell line (MCF-7) (Abstract). Proc Electron Microscopy Soc Am 35: 492–493, 1977.
    Google Scholar
  261. Soule H, Vasquez J, Ling AS, Albert S, Brennan MJA: Human cell line from a pleural infusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409–1414, 1974.
    Google Scholar
  262. Sharon N, Idalin L: Lectins: Cell agglutinating and sugar specific proteins. Science 177: 949–959, 1972.
    PubMed Google Scholar
  263. Hallowes RC, Bone EJ, Jones W: A new dimension in the culture of human breast.In Rajan and Richards (eds): 2nd International Symposium on Tissue Culture in Medical Research. Pergamon Press, London, 1980.
    Google Scholar
  264. Hallowes RC, Rudland PS, Hawkins RA, Lewis DJ, Bennett D, Durbin H: Comparison of the effects of hormones on DNA synthesis in cell cultures of non-neoplastic and neoplastic mammary epithelium from rats. Cancer Res 37: 2492–2504, 1977.
    PubMed Google Scholar
  265. Miller EC: Some current perspectives on chemical carcinogenesis in human and experimental animals: Presidential Address. Cancer Res 38: 1479–1496, 1978.
    PubMed Google Scholar
  266. Slaga TJ, Bowden GT, Scribner JD, Boutwell RK: Dose response studies on the ability of 7,12-dimethylbenz(a)anthracene and benz(a)anthracene to initiate skin tumors. J Natl Cancer Inst 53: 1337–1340, 1974.
    PubMed Google Scholar
  267. Walters MA: The induction of lung tumors by the injection of 9,10-dimethyl-1,2-benzanthracene (DMBA) into newborn suckling and young adult mice. Br J Cancer 20: 148–160, 1966.
    PubMed Google Scholar
  268. Wislocki PG, Juliana MM, MacDonald JS, Chou MW, Yang SK, Lu AYH: Tumorigenicity of 7,12-dimethylbenz(a)anthracene, its hydroxymethylated derivatives and selected dihydrodiols in the newborn mouse. Carcinogenesis 2: 511–514, 1981.
    PubMed Google Scholar
  269. Miller EC, Miller JA: Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 47: 2327–2345, 1981.
    PubMed Google Scholar
  270. DiGiovanni J, Juchau MR: Biotransformation and bioactivation of 7,12-dimethylbenz(a)anthracene (7,12-DMBA). Drug Metab Revs 11: 61–101, 1980.
    Google Scholar
  271. Boyland E, Sims P: Metabolism of polycyclic compounds. The metabolism of 7,12-dimethylbenz(a)anthracene by rat liver homogenates. Biochem J 95: 780–787, 1965.
    PubMed Google Scholar
  272. Chou MW, Easton GD, Yang SK: Metabolism of 7,12-dimethylbenz(a)anthracene and its methyl-hydroxylated metabolites: Formation of phenolic metabolites at the 2-position. Biochem Biophys Res Commun 88: 1085–1091, 1979.
    PubMed Google Scholar
  273. Chou MW, Yang SK: Identification of four trans-3,4-dihydrodiol metabolites of 7,12-dimethylbenz(a)anthracene and their in vitro DNA binding activities upon further metabolism. Proc Natl Acad Sci USA 75: 5466–5470, 1978.
    PubMed Google Scholar
  274. Chou MW, Yang SK: Combined reversed-phase and normal-phase high performance liquid chromatography in the purification and identification of 7,12-dimethylbenz(a) anthracene metabolites. J Chromatogr 185: 635–654, 1979.
    PubMed Google Scholar
  275. Sims P: Studies on the metabolism of 7-methylbenz(a) anthracene and 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives in rat liver and adrenal homogenates. Biochem Pharmacol 19: 2261–2275, 1970.
    PubMed Google Scholar
  276. Chou MW, Yang SK, Sydor W, Yang CS: Metabolism of 7,12-dimethylbenz(a)anthracene and 7-hydroxymethyl-12-methylbenz(a)anthracene by rat liver nuclei and microsomes. Cancer Res 41: 1559–1564, 1981.
    PubMed Google Scholar
  277. Diamond L, Sardet C, Rothblat G: The metabolism of 7,12-dimethylbenz(a)anthracene in cell cultures. Int J Cancer 3: 838–849, 1968.
    PubMed Google Scholar
  278. Gentil A, Lasne C, Chouroulinkov I: Metabolism and cytotoxicity of 7,12-dimethylbenz(a)anthracene by hamster, rat and rabbit embryo cell cultures. Xenobiotica 7: 221–233, 1977.
    PubMed Google Scholar
  279. Dao TL, Sinha DK: Mammary adenocarcinoma induced in organ culture by 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 49: 591–593, 1972.
    PubMed Google Scholar
  280. Richards J, Nandi S: Neoplastic transformation of rat mammary cells exposed to 7,12-dimethylbenz(a)anthracene or N-nitrosomethylurea in cell culture. Proc Natl Acad Sci USA 75: 3836–3840, 1978.
    PubMed Google Scholar
  281. Flesher JW, Soedigdo S, Kelley DR: Synthesis of metabolites of 7,12-dimethylbenz(a)anthracene. 4-Hydroxy-7,12-dimethylbenz(a)anthracene, 7-hydroxymethyl-12-methylbenz(a)anthracene, their methyl ethers and acetoxy derivatives. J Med Chem 10: 932–936, 1967.
    PubMed Google Scholar
  282. Wislocki PG, Gadek KM, Chou MW, Yang SK, Lu AYH: Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives. Cancer Res 40: 3661–3664, 1980.
    PubMed Google Scholar
  283. Jerina DM, Daly JW: Oxidation at carbon.In DV Parke and RL Smith (eds): Drug Metabolism. Taylor and Francis, Ltd, London, 1976, pp 15–33.
    Google Scholar
  284. Baird WM, Brookes P: Isolation of the hydrocarbondeoxyribonucleoside products from the DNA of mouse embryo cells treated in culture with 7-methylbenz(a)anthracene -3H. Cancer Res 33: 2378–2385, 1973.
    PubMed Google Scholar
  285. Cooper CS, Ribeiro O, Hewer A, Walsh C, Grover PL, Sims P: Additional evidence for the involvement of the 3,4-diol-1,2-oxides in the metabolic activation of 7,12-dimethylbenz(a)anthracene in mouse skin. Chem-Biol Interact 29: 357–367, 1980.
    PubMed Google Scholar
  286. Vigny P, Kindts M, Cooper CS, Grover PL, Sims P: Fluorescence spectra of nucleoside-hydrocarbon adducts formed in mouse skin treated with 7,12-dimethylbenz(a)anthracene. Carcinogenesis 2: 115–119, 1981.
    PubMed Google Scholar
  287. Moschel RC, Baird WM, Dipple A: Metabolic activation of the carcinogen 7,12-dimethylbenz(a)anthracene for DNA binding. Biochem Biophys Res Commun 76: 1092–1098, 1977.
    PubMed Google Scholar
  288. Dipple A, Nebzydoski JA: Evidence for the involvement of a diol-epoxide in the binding of 7,12-dimethylbenz(a)anthracene to DNA in cells in culture. Chem-Biol Interact 20: 17–26, 1978.
    PubMed Google Scholar
  289. Ivanovic V, Geacintov NE, Jeffrey AM, Fu PP, Harvey RG, Weinstein IB: Cell and microsome mediated binding of 7,12-dimethylbenz(a)anthracene to DNA studied by fluorescence spectroscopy. Cancer Lett 4: 131–140, 1978.
    PubMed Google Scholar
  290. Dipple A, Tomaszewski JE, Moschel RC, Bigger CAH, Nebzydoski JA, Egan M: Comparison of metabolismmediated binding to DNA of 7-hydroxymethyl-12-methylbenz(a)anthracene and 7,12-dimethylbenz(a)anthracene. Cancer Res 39: 1154–1158, 1979.
    PubMed Google Scholar
  291. Baird WM, Dipple A: Photosensitivy of DNA-bound 7,12-dimethylbenz(a)anthracene. Int J Cancer 20: 427–431, 1977.
    PubMed Google Scholar
  292. Baird WM: Effect of light on the hydrocarbon-DNA adducts formed in hamster embryo cells. Int J Cancer 22: 292–297, 1978.
    PubMed Google Scholar
  293. Grover PL, MacNicoll AD, Sims P, Easty GC, Neville AM: Polycyclic hydrocarbon activation and metabolism in epithelial cell aggregates prepared from human mammary tissue. Int J Cancer 26: 467–475, 1980.
    PubMed Google Scholar
  294. Tierney B, Hewer A, MacNicoll AD, Gervasi PG, Rattle H, Walsh C, Grover PL, Sims P: The formation of dihydrodiols by the chemical or enzymic oxidation of benz(a)anthracene and 7,12-dimethylbenz(a)anthracene. Chem-Biol Interact 23: 243–257, 1978.
    PubMed Google Scholar
  295. Marquardt H, Baker S, Tierney B, Grover PL, Sims P: Induction of malignant transformation and mutagenesis by dihydrodiolsderivedfrom 7,12-dimethylbenz(a)anthracene. Biochem Biophys Res Commun 85: 357–362, 1978.
    PubMed Google Scholar
  296. Marquardt H, Baker S, Tierney B, Grover PL, Sims P: Comparison of mutagenesis and malignant transformation by dihydrodiols from benz(a)anthracene and 7,12-dimethylbenz(a)anthracene. Br J Cancer 39: 540–547, 1979.
    PubMed Google Scholar
  297. Malaveille C, Bartsch H, Tierney B, Grover PL, Sims P: Microsome-mediated mutagenicities of the dihydrodiols of 7,12-dimethylbenz(a)anthracene: High mutagenic activity of the 3,4-dihydrodiol. Biochem Biophys Res Commun 83: 1468–1473, 1978.
    PubMed Google Scholar
  298. Slaga TJ, Gleason GL, DiGiovanni J, Sukumaran KB, Harvey RG: Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin. Cancer Res 39: 1934–1936, 1979.
    PubMed Google Scholar
  299. Yang SK, Chou MW, Roller PP: Potential proximate carcinogens of 7,12-dimethylbenz(a)anthracene: Characterization of two metabolically formed trans-3,4-dihydrodiols. J Amer Chem Soc 101: 237–239, 1979.
    Google Scholar
  300. Jerina DM, Yagi H, Lehr RE, Thakker DR, Schaeffer-Ridder M, Karle JM, Levin W, Wood AW, Chang RL, Conney AH: The bay region theory of carcinogenesis by polycyclic aromatic hydrocarbons.In HV Gelboin and POP Ts'o (eds): Polycyclic Hydrocarbons and Cancer. Environment, Chemistry and Metabolism. Academic Press, New York, 1978, Vol 1, pp 173–178.
    Google Scholar
  301. Flesher JW, Sydnor KL: Carcinogenicity of derivatives of 7,12-dimethylbenz(a)anthracene. Cancer Res 31: 1951–1954, 1971.
    PubMed Google Scholar
  302. Flesher JW, Tay LK: Reactions of the carcinogens 7-hydroxymethyl-12-methylbenz(a)anthracene and 7-acet-oxymethyl-12-methylbenz(a)anthracene with DNA. Res Commun Chem Path Pharmacol 22: 345–355, 1978.
    Google Scholar
  303. Tay LK, Sydnor KL, Flesher JW: Binding of 6-hydroxymethylbenzo(a)pyrene and 6-acetoxymethylbenzo(a)pyrene to DNA. Chem-Biol. Interact 25: 35–44, 1979.
    PubMed Google Scholar
  304. Rogan EG, Roth RW, Katomski-Beck PA, Laubscher JR, Cavalieri EL: Non-enzymatic ATP-mediated binding of hydroxymethyl derivatives of aromatic hydrocarbons to DNA. Chem-Biol Interact 31: 51–63, 1980.
    PubMed Google Scholar
  305. Roth RW, Grandjean C, Cavalieri EL: Comparative carcinogenicity of 7-methylbenz(a)anthracene and some of its derivatives at the methyl group (Abstract). Proc Amer Assoc Cancer Res 19: 203, 1978.
    Google Scholar
  306. Goshman LM, Heidelberger C: Binding of tritium-labeled polycyclic hydrocarbons to DNA of mouse skin. Cancer Res 27: 1678–1688, 1967.
    PubMed Google Scholar
  307. Duncan ME, Brookes P: The relation of metabolism to macromolecular binding of the carcinogen benzo(a)pyrene by mouse embryo cells in culture. Int J Cancer 6: 496–505, 1970.
    PubMed Google Scholar
  308. Huberman E, Sachs L: DNA binding and its relationship to carcinogenesis by different polycyclic hydrocarbons. Int J Cancer 19: 122–127, 1977.
    PubMed Google Scholar
  309. Duncan ME, Brookes P, Dipple A: Metabolism and binding to cellular macromolecules of a series of hydrocarbons by mouse embryo cells in culture. Int J Cancer 4: 813–819, 1969.
    PubMed Google Scholar
  310. Janss DH, Moon RC, Irving CC: The binding of 7,12-dimethylbenz(a)anthracene to mammary parenchyma DNA and protein in vivo. Cancer Res 32: 254–258, 1972.
    PubMed Google Scholar
  311. Marquardt H, Sternberg SS, Phillips FS: 7,12-dimethylbenz(a)anthracene and hepatic neoplasia in regenerating rat liver. Chem-Biol Interact 2: 401–403, 1970.
    PubMed Google Scholar
  312. Janss DH, Ben TL: Age-related modification of 7,12-dimethylbenz(a)anthracene binding to rat mammary gland DNA. J Natl Cancer Inst 60: 173–177, 1978.
    PubMed Google Scholar
  313. Ekelman KE, Milo GE: Cellular uptake, transport and macromolecular binding of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene by human cells in vitro. Cancer Res 38: 3026–3032, 1978.
    PubMed Google Scholar
  314. Cleaver JE: Defective repair replication of DNA in Xeroderma pigmentosum. Nature 218: 652–656, 1968.
    PubMed Google Scholar
  315. Setlow RB, Regan JD, German J, Carrier WL: Evidence that Xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA. Proc Natl Acad Sci USA 64: 1035–1041, 1969.
    PubMed Google Scholar
  316. Regan JD, Francis AA, Dunn WC, Hernandez O, Yagi H, Jerina DM: Repair of DNA damaged by mutagenic metabolites of benzo(a)pyrene in human cells. Chem-Biol Interact 20: 279–287, 1978.
    PubMed Google Scholar
  317. Maher VM, Birch N, Otto JR, McCormick JJ: Cytotoxicity of carcinogenic aromatic amides in normal and Xeroderma pigmentosum fibroblasts with different DNA repair capabilities. J Natl Cancer Inst 54: 1287–1294, 1975.
    PubMed Google Scholar
  318. Shìnohara K, Cerutti PA: Excision repair of benzo(a)pyrene-deoxyguanosine adducts in baby hamster kidney 21/C13 cells and in secondary mouse embryo fibroblasts C57BL/6J. Proc Natl Acad Sci USA 74: 979–983, 1977.
    PubMed Google Scholar
  319. Day RS, Scudiero D, Dimattina M: Excision repair by human fibroblasts of DNA damaged by r-7, t-8-dihydroxy-t-9, 10-oxy-7, 8, 9, 10-tetrahydrobenzo(a)pyrene. Mut Res 50: 383–394, 1978.
    Google Scholar
  320. Ikenaga M, Takebe H, Ishii Y: Excision repair of DNA base damage in human cells treated with the chemical carcinogen 4-nitroquinoline-1-oxide. Mut Res 43: 415–427, 1977.
    Google Scholar
  321. Heflich RH, Hazzard RM, Lommel L, Scribner JD, Maher VM, McCormick JJ: A comparison of the DNA binding, cytotoxicity and repair synthesis induced in human fibroblasts by reactive derivatives of aromatic amide carcinogens. Chem-Biol Interact 29: 43–56, 1980.
    PubMed Google Scholar
  322. Russel GR, Patrick EJ: Effects of variations in nucleoside pool sizes on comparisons of the incorporation of [3H]-thymidine into isolated rat liver cells. Cancer Res 40: 3719–3722, 1980.
    PubMed Google Scholar
  323. Cleaver JE, Holford RM: Investigation into the incorporation of [3H]-thymidine into DNA of L strain cells and the formation of a pool of phosphorylated derivatives during pulse labeling. Biochem Biophys Acta 103: 654–671, 1965.
    PubMed Google Scholar
  324. Hell E, Berry RJ, Lajtha LG: A pitfall in high specific activity tracer studies. Nature 185: 47, 1960.
    Google Scholar
  325. Lambert B, Ringborg U, Skoog L: Age-related decrease of ultraviolet light-induced DNA repair synthesis in human peripheral leukocytes. Cancer Res 39: 2792–2795, 1979.
    PubMed Google Scholar
  326. Williams GM: Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures. Cancer Res 37: 1845–1851, 1977.
    PubMed Google Scholar
  327. Smith CA, Hanawalt PC: Repair replication in human cells. Simplified determination utilizing hydroxyurea. Biochem Biophys Acta 432: 336–347, 1976.
    PubMed Google Scholar
  328. Dipple A, Hayes ME: Differential excision of carcinogenic hydrocarbon-DNA adducts in mouse embryo cell cultures. Biochem Biophys Res Commun 91: 1225–1231, 1979.
    PubMed Google Scholar
  329. Amacher DE, Elliott JA, Lieberman MW: Differences in removal of acetylaminofluorene and pyrimidine dimers from the DNA of cultured mammalian cells. Proc Natl Acad Sci USA 74: 1553–1557, 1977.
    PubMed Google Scholar
  330. Slor H: Induction of unscheduled DNA synthesis by the carcinogen 7-bromomethylbenz(a)anthracene and its removal from the DNA of normal and Xeroderma pigmentosum lymphocytes. Mut Res 19: 231–235, 1973.
    Google Scholar
  331. Heflich RH, Dorney DJ, Maher VM, McCormick JJ: Reactive derivatives of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene cause Sl nuclease sensitive sites in DNA and ‘UV-like’ repair. Biochem Biophys Res Commun 77: 634–641, 1977.
    PubMed Google Scholar
  332. Yang LL, Maher VM, McCormick JJ: Error-free excision of the cytotoxic, mutagenic N2-deoxyguanosine DNA adduct formed in human fibroblasts by (±)-7_β_,8_α_-dihydroxy-9_α_, 10_α_-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene. Proc Natl Acad Sci USA 77: 5933–5937, 1980.
    PubMed Google Scholar
  333. Dipple A, Roberts JJ: Excision of 7-bromomethylbenz(a) anthracene-DNA adducts in replicating mammalian cells. Biochemistry 16: 1499–1503, 1977.
    PubMed Google Scholar
  334. Lieberman MW, Dipple A: Removal of bound carcinogen during DNA repair in nondividing human lymphocytes. Cancer Res 32: 1855–1860, 1972.
    PubMed Google Scholar
  335. Feldman G, Remsen J, Shinohara K, Cerutti PA: Excisability and persistence of benzo(a)pyrene DNA adducts in epithelioid human lung cells. Nature 274: 796–798, 1978.
    PubMed Google Scholar
  336. Dell'Orco RT, Whittle WL: Unscheduled DNA synthesis in confluent and mitotically arrested populations of aging human diploid fibroblasts. Mech Aging Dev 8: 269–279, 1978.
    PubMed Google Scholar
  337. Goldstein S: The role of DNA repair in aging of cultured fibroblasts from Xeroderma pigmentosum and normals (35655). Proc Soc Exper Biol Med 137: 730–734, 1971.
    Google Scholar
  338. Painter RB, Clarkson JM, Young BR: Ultraviolet-induced repair replication in aging diploid human cells (WI-38). Radiat Res 56: 560–564, 1973.
    PubMed Google Scholar
  339. Geschickter CF: Diseases of the breast: Diagnosis, pathology, treatment. Lipincott, Philadelphia, 1945, pp 1–15.
    Google Scholar
  340. Tanner JM: Growth at adolescence. Blackwell Scientific Publishing Ltd, Oxford, 1962.
    Google Scholar
  341. Geschickter CF, Lewis D: Pregnancy and lactation changes in fibroadenoma of the breast. Br Med J 1: 499–504, 1938.
    Google Scholar
  342. Russo JR, Wilgus G, Russo IH: Mammary gland differentiation as a determinant of tumor incidence after 7,12-dimethylbenz(a)anthracene administration (Abstract). Proc Mammary Cancer Exper Animals and Man 11: 51, 1978.
    Google Scholar
  343. Russo J, Russo IH: Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol 100: 497–511, 1980.
    PubMed Google Scholar
  344. Jenssen HM, Wellings SR: Preneoplastic lesions of the human mammary gland transplanted into the nude athymic mouse. Cancer Res 36: 2605–2610, 1976.
    PubMed Google Scholar
  345. Rifkind AB, Kalin HE, Ross GT: Follicle-stimulating hormone(FSH)and luteinizing hormone (LH) in the urine of prepubertal children, J Clin Invest 46: 1925–1931, 1967.
    PubMed Google Scholar
  346. Meyer SJ: Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias as measured by tritiated thymidine effects of menstrual phase, age and oral contraceptive hormones. Hum Pathol 8: 67–81, 1977.
    PubMed Google Scholar

Download references